jane larkindale - why are c-path drug development tools important in rare disease drug development?
Published 4 years ago • 30 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
1:59
jane larkindale - what is c-path doing that is unique in drug development for rare disease?
-
1:39
the importance of data sharing in rare disease drug development - ramona walls, c-path
-
3:25
vp of c-path rare and orphan disease programs collin hovinga talks rare disease drug development
-
4:12
why are high-quality standardized databases so critical for drug development?
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
45:31
derisking rare disease drug development and measuring impact and outcomes with andrew lo
-
7:40
aortitis - paths to the problem
-
3:33
4 signs of addictive behavior from our expert
-
11:54
the challenge of drug development
-
2:05
how can patients and advocates help accelerate drug development?
-
59:23
what does patient focused drug development look like for rare diseases sd 480p
-
0:37
diane stephenson - why is c-path so important in the drug development space?
-
1:03
navigating expanded access - rare disease drug development series preview
-
1:42
jane larkindale - how can data sharing reduce the cost of clinical trials?
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
2:26
how does trxa help bridge the drug development "valley of death?"
-
57:08
industry perspective on drug development in rare diseases
-
1:24:07
regulatory pathway and applications in drug development for rare diseases
-
3:27
what does the fda hope to achieve through developing the rare disease cures accelerator?
-
1:34:43
eatx rdca-dap - webinar on ‘data sharing and analysis to support rare disease drug development‘
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development